Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obicetrapib as Adjunct to High-Intensity Statin Therapy (ROSE)
NCT04753606Phase 2Completed
- Sponsor
- NewAmsterdam Pharma
- Start
- Feb 2021
- Primary completion
- May 2021
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of obicetrapib in hypercholesterolemia, sponsored by NewAmsterdam Pharma. Started Feb 2021; status: completed.
02
Drugs
obicetrapib
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04753606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04753606.